Adebowale Adeyemo1, Christopher Esezobor2, Adaobi Solarin3, Asiri Abeyagunawardena4, Jameela A Kari5, Sherif El Desoky5, Larry A Greenbaum6, Margret Kamel6, Mahmoud Kallash7, Cynthia Silva8, Alex Young9, Tracey E Hunley10, Nilka de Jesus-Gonzalez11, Tarak Srivastava12, Rasheed Gbadegesin13. 1. Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD. Electronic address: adeyemoa@mail.nih.gov. 2. Department of Pediatrics, Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. 3. Department of Pediatrics, Lagos State University Teaching Hospital (LASUTH), Lagos, Nigeria. 4. Department of Pediatrics, University of Peradeniya, Sri Lanka. 5. Pediatric Nephrology Center of Excellence, Department of Pediatrics, King Abdulaziz University, Jeddah, Saudi Arabia. 6. Division of Pediatric Nephrology, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA. 7. Department of Pediatrics, State University of New York, Buffalo, NY. 8. Division of Nephrology, Connecticut Children's Hospital, Hartford, CT. 9. Division of Nephrology, Department of Pediatrics, and Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC. 10. Division of Nephrology, Department of Pediatrics, Vanderbilt University, Nashville, TN. 11. Department of Pediatrics, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico. 12. Department of Nephrology, Children Mercy Hospital, Kansas City, MO. 13. Division of Nephrology, Department of Pediatrics, and Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC. Electronic address: rasheed.gbadegesin@duke.edu.
Abstract
BACKGROUND: Few data exist for the genetic variants underlying the risk for steroid-sensitive nephrotic syndrome (SSNS) in children. The objectives of this study were to evaluate HLA-DQA1 and APOL1 variants as risk factors for SSNS in African American children and use classic HLA antigen types and amino acid inference to refine the HLA-DQA1 association. STUDY DESIGN: Case-control study. SETTING & PARTICIPANTS: African American children with SSNS or steroid-resistant nephrotic syndrome (SRNS) were enrolled from Duke University and centers participating in the Midwest Pediatric Nephrology Consortium. FACTOR: Genetic variants in HLA-DQA1 (C34Y [rs1129740]; F41S [rs1071630]) and APOL1 high-risk alleles. OUTCOMES: SSNS and SRNS. MEASUREMENTS: Direct sequencing for the HLA-DQA1 and APOL1 variants in 115 African American children (65 with SSNS and 50 with SRNS). Imputation of classic HLA alleles and amino acids was done in 363 South Asian children. RESULTS: The 2 HLA-DQA1 variants were significantly associated with SSNS in African American children (C34Y: P=5.7 × 10-11; OR, 3.53; 95% CI, 2.33-5.42; F41S: P=1.2 × 10-13; OR, 4.08; 95% CI, 2.70-6.28), but not with SRNS (C34Y: P=0.6; F41S: P=0.2). APOL1 high-risk variants were not associated with SSNS (P=0.5) but showed significant associations with SRNS (P=1.04 × 10-7; OR, 4.17; 95% CI, 2.23-7.64). HLA-DQA1*0201, HLA-DQB1*0201, and HLA-DRB1*0701 were the classic HLA alleles with the most significant associations with SSNS risk. The most significantly associated amino acid positions were HLA-DQα1 56 and 76 (both P=2.8 × 10-7). Conditional analysis revealed that these variants most likely account for the observed association. LIMITATIONS: Modest sample size and limited statistical power to detect small to moderate effect sizes. Children studied may not be representative of all African American children in the United States. CONCLUSIONS: HLA-DQA1 is a risk locus for SSNS, but not SRNS, in African American children, consistent with its role in SSNS risk in children of European, Asian, and African ancestries. There is little evidence of a significant role for the APOL1 high-risk alleles in childhood SSNS in African American children. Refinement of the HLA-DQA1 association identified the critical classic HLA antigen types and amino acids of the HLA-DQ α1 molecule.
BACKGROUND: Few data exist for the genetic variants underlying the risk for steroid-sensitive nephrotic syndrome (SSNS) in children. The objectives of this study were to evaluate HLA-DQA1 and APOL1 variants as risk factors for SSNS in African American children and use classic HLA antigen types and amino acid inference to refine the HLA-DQA1 association. STUDY DESIGN: Case-control study. SETTING & PARTICIPANTS: African American children with SSNS or steroid-resistant nephrotic syndrome (SRNS) were enrolled from Duke University and centers participating in the Midwest Pediatric Nephrology Consortium. FACTOR: Genetic variants in HLA-DQA1 (C34Y [rs1129740]; F41S [rs1071630]) and APOL1 high-risk alleles. OUTCOMES: SSNS and SRNS. MEASUREMENTS: Direct sequencing for the HLA-DQA1 and APOL1 variants in 115 African American children (65 with SSNS and 50 with SRNS). Imputation of classic HLA alleles and amino acids was done in 363 South Asian children. RESULTS: The 2 HLA-DQA1 variants were significantly associated with SSNS in African American children (C34Y: P=5.7 × 10-11; OR, 3.53; 95% CI, 2.33-5.42; F41S: P=1.2 × 10-13; OR, 4.08; 95% CI, 2.70-6.28), but not with SRNS (C34Y: P=0.6; F41S: P=0.2). APOL1 high-risk variants were not associated with SSNS (P=0.5) but showed significant associations with SRNS (P=1.04 × 10-7; OR, 4.17; 95% CI, 2.23-7.64). HLA-DQA1*0201, HLA-DQB1*0201, and HLA-DRB1*0701 were the classic HLA alleles with the most significant associations with SSNS risk. The most significantly associated amino acid positions were HLA-DQα1 56 and 76 (both P=2.8 × 10-7). Conditional analysis revealed that these variants most likely account for the observed association. LIMITATIONS: Modest sample size and limited statistical power to detect small to moderate effect sizes. Children studied may not be representative of all African American children in the United States. CONCLUSIONS:HLA-DQA1 is a risk locus for SSNS, but not SRNS, in African American children, consistent with its role in SSNS risk in children of European, Asian, and African ancestries. There is little evidence of a significant role for the APOL1 high-risk alleles in childhood SSNS in African American children. Refinement of the HLA-DQA1 association identified the critical classic HLA antigen types and amino acids of the HLA-DQ α1 molecule.
Authors: Jonathan H Pelletier; Karan R Kumar; Rachel Engen; Adam Bensimhon; Jennifer D Varner; Michelle N Rheault; Tarak Srivastava; Caroline Straatmann; Cynthia Silva; T Keefe Davis; Scott E Wenderfer; Keisha Gibson; David Selewski; John Barcia; Patricia Weng; Christoph Licht; Natasha Jawa; Mahmoud Kallash; John W Foreman; Delbert R Wigfall; Annabelle N Chua; Eileen Chambers; Christoph P Hornik; Eileen D Brewer; Shashi K Nagaraj; Larry A Greenbaum; Rasheed A Gbadegesin Journal: Pediatr Nephrol Date: 2018-07-07 Impact factor: 3.714
Authors: Hanna Debiec; Claire Dossier; Eric Letouzé; Christopher E Gillies; Marina Vivarelli; Rosemary K Putler; Elisabet Ars; Evelyne Jacqz-Aigrain; Valery Elie; Manuela Colucci; Stéphanie Debette; Philippe Amouyel; Siham C Elalaoui; Abdelaziz Sefiani; Valérie Dubois; Tabassome Simon; Matthias Kretzler; Jose Ballarin; Francesco Emma; Matthew G Sampson; Georges Deschênes; Pierre Ronco Journal: J Am Soc Nephrol Date: 2018-06-14 Impact factor: 10.121
Authors: Pepe M Ekulu; Agathe B Nkoy; Oyindamola C Adebayo; Orly K Kazadi; Michel N Aloni; Fanny O Arcolino; Rene M Ngiyulu; Jean-Lambert E Gini; François B Lepira; Lamberthus P Van den Heuvel; Elena N Levtchenko Journal: Pediatr Nephrol Date: 2020-04-06 Impact factor: 3.714
Authors: Shipra Agrawal; Michael L Merchant; Jiro Kino; Ming Li; Daniel W Wilkey; Adam E Gaweda; Michael E Brier; Melinda A Chanley; Jessica R Gooding; Susan J Sumner; Jon B Klein; William E Smoyer Journal: Kidney Int Rep Date: 2019-09-19